Ustekinumab in Crohn's disease: Real‐world outcomes from the Sicilian network for inflammatory bowel diseases

BACKGROUND AND AIM: Ustekinumab is approved in Europe for the treatment of moderate to severe Crohn's disease (CD). Italian real‐life data are scarce, so the aim of this study was to assess the effectiveness and safety of ustekinumab in an Italian cohort of CD patients. METHODS: Data of patient...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:JGH Open
Main Authors: Viola, Anna, Muscianisi, Marco, Macaluso, Fabio S, Ventimiglia, Marco, Cappello, Maria, Privitera, Antonino C, Magnano, Antonio, Pluchino, Dario, Magrì, Giovanni, Ferracane, Concetta, Mocciaro, Filippo, Garufi, Serena, Giuffrida, Enrica, Costantino, Giuseppe, Fiocco, Gabriele, Grova, Mauro, Guida, Laura, Alibrandi, Angela, Orlando, Ambrogio, Fries, Walter
Format: Artigo
Sprog:Inglês
Udgivet: Wiley Publishing Asia Pty Ltd 2021
Fag:
Original Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7936616/
https://ncbi.nlm.nih.gov/pubmed/33732883
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jgh3.12502
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker